Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
International Strategies for Tropical Disease Treatments - Experiences with Praziquantel - EDM Research Series No. 026
(1998; 113 pages) View the PDF document
Table of Contents
View the documentAbstract
View the documentAcknowledgments
View the documentInformation on authors
View the documentExchange rates used in the report
Open this folder and view contentsChapter 1: Policies for praziquantel*
Open this folder and view contentsChapter 2: Bayer & E. Merck: Discovery and development of praziquantel*
Open this folder and view contentsChapter 3: Shin Poong Pharmaceutical Co.: Process development in the Republic of Korea*
Open this folder and view contentsChapter 4: The Egyptian International Pharmaceutical Industries Co.: Praziquantel formulation*
Open this folder and view contentsChapter 5: The international supply of praziquantel*
Open this folder and view contentsChapter 6: Demand for praziquantel and national distribution*
Open this folder and view contentsChapter 7: Prices and production costs of praziquantel*
View the documentOther documents in the DAP Research Series
View the documentDAP Research Series No. 26
 

Exchange rates used in the report

(US$ to local currency)

Year

Egypt
(L.E.)

Germany
(mark)

Korea
(won)

1981

0.70

2.30

681

1982

0.80

2.40

731

1983

0.90

2.60

776

1984

0.90

2.80

806

1985

0.96

2.90

870

1986

1.07

2.20

882

1987

1.27

1.80

823

1988

1.76

1.80

731

1989

1.94

1.90

680

1990

2.23

1.60

716

1991

3.01

1.70

761

1992

3.32

1.60

788

1993

3.33

1.70

808

1994

3.37

1.60

780

1995

3.39

1.45

774

Source: International Monetary Fund

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014